{{Rsnum
|rsid=2206593
|Gene=PTGS2
|Chromosome=1
|position=186673297
|Orientation=plus
|GMAF=0.04316
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PTGS2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 8.9 | 91.1
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 3.5 | 96.5
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 14.9 | 85.1
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 8.8 | 91.2
| MKK | 0.0 | 0.6 | 99.4
| TSI | 0.0 | 24.8 | 75.2
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19820421
|Title=The Effect of Genetic Polymorphisms of Cyclooxygenase 2 on Acute Pancreatitis in Turkey
}}

{{PMID Auto
|PMID=21705955
|Title=Cyclooxygenase-2 polymorphisms and pancreatic cancer susceptibility
}}

{{PMID Auto
|PMID=18454203
|Title=Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression.
|OA=1
}}

{{PMID Auto
|PMID=19318492
|Title=Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=19437564
|Title=No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}